Exact Mass: 438.1063
Exact Mass Matches: 438.1063
Found 482 metabolites which its exact mass value is equals to given mass value 438.1063
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Hamaudol 3-glucoside
Sec-o-Glucosylhamaudol is a member of chromenes. sec-o-Glucosylhamaudol is a natural product found in Ostericum grosseserratum, Saposhnikovia divaricata, and other organisms with data available. Sec-O-Glucosylhamaudol is a natural compound extracted from Peucedanum japonicum Thunb, decreases levels of μ-opioid receptor, with analgesic effect[1]. Sec-O-Glucosylhamaudol is a natural compound extracted from Peucedanum japonicum Thunb, decreases levels of μ-opioid receptor, with analgesic effect[1]. Sec-O-Glucosylhamaudol is a natural compound extracted from Peucedanum japonicum Thunb, decreases levels of μ-opioid receptor, with analgesic effect[1].
Glaucolide B
Riboflavin cyclic-4',5'-phosphate
Riboflavin cyclic-4,5-phosphate, also known as cfmn or cyclic flavin mononucleotide, is a member of the class of compounds known as flavins. Flavins are compounds containing a flavin (7,8-dimethyl-benzo[g]pteridine-2,4-dione) moiety, with a structure characterized by an isoalloaxzine tricyclic ring. Riboflavin cyclic-4,5-phosphate is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Riboflavin cyclic-4,5-phosphate can be found in a number of food items such as sea-buckthornberry, horseradish tree, malabar spinach, and wild rice, which makes riboflavin cyclic-4,5-phosphate a potential biomarker for the consumption of these food products. Riboflavin cyclic-4,5-phosphate is part of the Glycerolipid metabolism, and RIG-I-like receptor signaling pathway pathways. It is a substrate for: Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing).
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[(E)-N-hydroxy-C-(3-methylsulfanylpropyl)carbonimidoyl]sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
7-Hydroxy-5-(4-hydroxy-2-oxopentyl)-2-methylchromone 7-glucoside
7-Hydroxy-5-(4-hydroxy-2-oxopentyl)-2-methylchromone 7-glucoside is found in green vegetables. 7-Hydroxy-5-(4-hydroxy-2-oxopentyl)-2-methylchromone 7-glucoside is a constituent of Chinese rhubarb (Rheum sp.) Constituent of Chinese rhubarb (Rheum species). 7-Hydroxy-5-(4-hydroxy-2-oxopentyl)-2-methylchromone 7-glucoside is found in green vegetables.
Cnidimol 7-glucoside
Constituent of Angelica archangelica (angelica). Cnidimol 7-glucoside is found in fats and oils, herbs and spices, and green vegetables. Cnidimol 7-glucoside is found in fats and oils. Cnidimol 7-glucoside is a constituent of Angelica archangelica (angelica).
Silica aerogel
Silica aerogel is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]")
Loquatoside
Loquatoside is found in fruits. Loquatoside is a constituent of the fruit of Eriobotrya japonica (loquat). Constituent of the fruit of Eriobotrya japonica (loquat). Loquatoside is found in loquat and fruits.
5-(2,4-Dioxo-thiazolidin-5-ylmethyl)-2-methoxy-N-(4-trifluoromethyl-benzyl)-benzamide(KRP297)
(4S,6R)-6-[(1E)-4,4-Bis(4-fluorophenyl)-3-(1-methyltetrazol-5-yl)buta-1,3-dienyl]-4-hydroxyoxan-2-one
N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide
5-((2,4-Dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide
Sec-o-Glucosylhamaudol
Cichorioside K
Cichorioside k is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Cichorioside k can be found in endive, which makes cichorioside k a potential biomarker for the consumption of this food product.
Remimazolam
N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
8beta-Acetoxy-10beta-hydroxyhirsutinolide 1,13-O-diacetate
Thonningin C
1,10-Epoxy-14-hydroxyhypocretenolide beta-D-glucopyranoside
[4R-(4R*,6S*,7R*,10R*)]-4,6-bis(Acetyloxy)-3-[(acetyloxy)methyl]-5,6,7,8,9,10-hexahydro-7-hydroxy-6,10-dimethyl-7,10-epoxycyclodeca[b]furan-2(4H)-one
[3-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl 3,4-dihydroxybenzoate
(4S,5E,7Z,12R,14Z,17Z)-4-hydroxy-17,18-didehydrobromovulone-3
15-hydroxygermacra-1(10),4,11(13)-trien-(12,6);(14,8)-diolide 15-O-beta-D-glucopyranoside
1,3,6,7-tetrahydroxyxanthone-4-beta-D-glucopyranoside|isomangiferin
1,8,13-Tri-Ac-1,4-Epoxy-1,8,10,13-tetrahydroxy-5,7(11)-germacradien-12,6-olide
3-(beta-D-glucopyranosyloxy)-7,7a-dihydro-6,7-dihydroxy-1a-(3-methyl-2-butenyl)naphth<2,3-b>oxiren-2(1aH)-one|3-(beta-D-glucopyranosyloxy)-7,7a-dihydro-6,7-dihydroxy-1a-(3-methyl-2-butenyl)naphth[2,3-b]oxiren-2(1aH)-one
(2E)-3-[3-(3,4-dihydroxybenzyl)-6-hydroxy-2,4-dimethoxyphenyl]-1-(3,4-dihydroxyphenyl)prop-2-en-1-one|3,4,6-trihydroxy-2,4-dimethoxy-3-(3,4-dihydroxybenzyl)chalcone
2-O-beta-D-glucopyranosyl-4,4,6-trihydroxy-3-methoxybenzophenone|tenuiside D
foliamangiferoside 2,4,6-trihyroxy-4-methoxybenzophenone-2-O-beta-D-glucopyranoside
5-((S)-2-oxo-4-hydroxypentyl)-2-(beta-glucopyranosyl-oxy-methyl)chromone
3-hydroxy-5-methylphenol 1-O-beta-D-(3-O-galloyl)glucopyranoside|cleyeratannin A
(4aS,5R,6S)-5-ethenyl-6-(beta-D-glucopyranosyloxy)-4,4a,5,6-tetrahydro-1-oxo-1H,3H-pyrano[3,4-c]pyran-3-sulfonic acid
Dehydroascorbic acid-2,3-Bisbenzoylhydrazone, 5,6-di-Ac
(2S,3R)-3,10-dihydroxy-9-O-(6-hydroxy-7-O-methyl-2-hydroxymethyldihydrobenzofuran-3-yl)dibenz--pyran-6-one
D-Arabino-Hexose, 2-deoxy-, diethyl mercaptal, tetraacetate
3-hydroxy-5-methylphenol 1-O-beta-D-(6-galloyl)glucopyranoside|3-hydroxy-5-methylphenol 1-O-beta-D-(6-O-galloyl)glucopyranoside|3-Hydroxy-5-methylphenol 1-O-??-D-(6-galloyl)glucopyranoside
2,3,6,8,9,12-Hexamethoxybenzo[1,2-b:4,5-b]bisbenzofuran
5-Amino-imidazol-carbonsaeure-(4)-succinylamid-ribotid|N-[5-amino-1-(O5-phosphono-beta-6D-ribofuranosyl)-1H-imidazole-4-carbonyl]-succinamic acid
(alphaR)-3-O-beta-D-xylopyranosyl-alpha,3,4,2,4-pentahydroxydihydrochalcone
2-(1-Methylethenyl)-3,4-dimethoxy-5-hydroxy-6-(3,4-dimethoxyphenyl)-7H-furo[3,2-g][1]benzopyran-7-one
2alpha,3beta-dihydroxycyclohex-4-en-1beta-yl 2-O-[(E)-p-coumaroyl]-beta-D-glucopyranoside
7-[(beta-D-glucopyranosyl)oxy]-5-hydroxy-8-[(2E)-4-hydroxy-3-methylbut-2-enyl]-2-methyl-4H-1-benzopyran-4-one
(E)-1-(glutathion-S-yl)-N-hydroxy-omega-(methylsulfanyl)butan-1-imine
MonnierisideG
4-hydroxy-7-methyl-2-[2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl]-2,3-dihydrofuro[3,2-g]chromen-5-one
[3-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl 3,4-dihydroxybenzoate
4-hydroxy-7-methyl-2-[2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl]-2,3-dihydrofuro[3,2-g]chromen-5-one
[3-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl 3,4-dihydroxybenzoate_major
Ala Cys Asp Met
Ala Cys Met Asp
Ala Asp Cys Met
Ala Asp Met Cys
Ala Met Cys Asp
Ala Met Asp Cys
Cys Ala Asp Met
Cys Ala Met Asp
Cys Cys Asp Val
Cys Cys Val Asp
Cys Asp Ala Met
Cys Asp Cys Val
Cys Asp Asp Ser
Cys Asp Met Ala
Cys Asp Ser Asp
Cys Asp Thr Thr
Cys Asp Val Cys
Cys Glu Gly Met
Cys Glu Met Gly
Cys Glu Ser Thr
Cys Glu Thr Ser
Cys Gly Glu Met
Cys Gly Met Glu
Cys Met Ala Asp
Cys Met Asp Ala
Cys Met Glu Gly
Cys Met Gly Glu
Cys Ser Asp Asp
Cys Ser Glu Thr
Cys Ser Thr Glu
Cys Thr Asp Thr
Cys Thr Glu Ser
Cys Thr Ser Glu
Cys Thr Thr Asp
Cys Val Cys Asp
Cys Val Asp Cys
Asp Ala Cys Met
Asp Ala Met Cys
Asp Cys Ala Met
Asp Cys Cys Val
Asp Cys Asp Ser
Asp Cys Met Ala
Asp Cys Ser Asp
Asp Cys Thr Thr
Asp Cys Val Cys
Asp Asp Cys Ser
Asp Asp Ser Cys
Asp Met Ala Cys
Asp Met Cys Ala
Asp Met Ser Ser
Asp Ser Cys Asp
Asp Ser Asp Cys
Asp Ser Met Ser
Asp Ser Ser Met
Asp Thr Cys Thr
Asp Thr Thr Cys
Asp Val Cys Cys
Glu Cys Gly Met
Glu Cys Met Gly
Glu Cys Ser Thr
Glu Cys Thr Ser
Glu Gly Cys Met
Glu Gly Met Cys
Glu Met Cys Gly
Glu Met Gly Cys
Glu Ser Cys Thr
Glu Ser Thr Cys
Glu Thr Cys Ser
Glu Thr Ser Cys
Gly Cys Glu Met
Gly Cys Met Glu
Gly Glu Cys Met
Gly Glu Met Cys
Gly Met Cys Glu
Gly Met Glu Cys
Met Ala Cys Asp
Met Ala Asp Cys
Met Cys Ala Asp
Met Cys Asp Ala
Met Cys Glu Gly
Met Cys Gly Glu
Met Asp Ala Cys
Met Asp Cys Ala
Met Asp Ser Ser
Met Glu Cys Gly
Met Glu Gly Cys
Met Gly Cys Glu
Met Gly Glu Cys
Met Ser Asp Ser
Met Ser Ser Asp
Ser Cys Asp Asp
Ser Cys Glu Thr
Ser Cys Thr Glu
Ser Asp Cys Asp
Ser Asp Asp Cys
Ser Asp Met Ser
Ser Asp Ser Met
Ser Glu Cys Thr
Ser Glu Thr Cys
Ser Met Asp Ser
Ser Met Ser Asp
Ser Ser Asp Met
Ser Ser Met Asp
Ser Thr Cys Glu
Ser Thr Glu Cys
Thr Cys Asp Thr
Thr Cys Glu Ser
Thr Cys Ser Glu
Thr Cys Thr Asp
Thr Asp Cys Thr
Thr Asp Thr Cys
Thr Glu Cys Ser
Thr Glu Ser Cys
Thr Ser Cys Glu
Thr Ser Glu Cys
Thr Thr Cys Asp
Thr Thr Asp Cys
Val Cys Cys Asp
Val Cys Asp Cys
Val Asp Cys Cys
Silica aerogel
7-Hydroxy-5-(4-hydroxy-2-oxopentyl)-2-methylchromone 7-glucoside
Cnidimol 7-glucoside
Loquatoside
2-(4-Hydroxy-7-methyl-5-oxo-2,3-dihydro-5H-furo[3,2-g]chromen-2-yl)-2-propanyl hexopyranoside
[(2R,3R,4S,5R,6S)-3,5,6-triacetyloxy-4-phenylmethoxyoxan-2-yl]methyl acetate
Dolasetron (Mesylate hydrate)
Dolasetron Mesylate hydrate (MDL-73147EF hydrate) is a serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy.
Phenyl 2,4,6-Tri-O-acetyl-3-O-allyl-1-thio-beta-D-glucopyranoside
2-[(2-cyanoethyl)[4-[(6-nitrobenzothiazol-2-yl)azo]phenyl]amino]ethyl acetate
n-(8-maleimidocapryloxy)sulfosuccinimide, sodium salt
1-(3,4-difluorophenyl)-7,7-dimethyl-3-[(3-nitrophenyl)methyl]-6,8-dihydroquinoline-2,5-dione
Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-alpha-D-glucopyranoside
5-(2,4-difluorophenyl)-2-hydroxy-N-[4-nitro-3-(trifluoromethyl)phenyl]benzamide
Benzenesulfonamide, N-[(1S)-2-amino[1,1-binaphthalen]-2-yl]-4-methyl
1,1-(BUTANE-1,4-DIYL)BIS[4-AZA-1-AZONIABICYCLO[2.2.2]OCTANE] DIBROMIDE
Bruceolide
A quassinoid isolated from Brucea javanica and Brucea sumatrana and has been shown to exhibit antimalarial activity.
(2S)-2-[[5-[3-(2,6-diamino-4-oxo-1H-pyrimidin-5-yl)propylamino]thiophene-2-carbonyl]amino]pentanedioic acid
4-[5-(4-Methoxyphenyl)-2-oxazolyl]-1-methylpyridinium 4-methylbenzenesulfonate
Spiraprilat
An azaspiro compound that is spirapril in which the ethyl ester group has been hydrolysed to the corresponding carboxylic acid group. It is the active metabolite of the angiotensin-converting enzyme (ACE) inhibitor spirapril. C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor
(2s)-3-(1-{[2-(2-Chlorophenyl)-5-Methyl-1,3-Oxazol-4-Yl]methyl}-1h-Indol-5-Yl)-2-Ethoxypropanoic Acid
5-{3-[3-(2,4-Dichloro-benzoyl)-ureido]-2-methyl-phenoxy}-pentanoic acid
4-{4-[3-(2,4-Dichloro-benzoyl)-ureido]-2,3-dimethyl-phenoxy}-butyric acid
CNS-7056
N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
10-[(2R,3R)-2,3-dihydroxy-3-[(4S)-2-hydroxy-2-oxo-1,3,2lambda5-dioxaphospholan-4-yl]propyl]-7,8-dimethylbenzo[g]pteridine-2,4-dione
(E)-2-hydroxy-1-[4,5,7,10-tetrahydroxy-3-(3-oxobutanoyl)anthracen-2-yl]pent-2-ene-1,4-dione
(2S)-2-amino-5-[[(1R)-1-carboxy-2-(1H-indol-3-ylmethylcarbamothioylsulfanyl)ethyl]amino]-5-oxopentanoic acid
6-[(1E)-4,4-bis(4-fluorophenyl)-3-(1-methyltetrazol-5-yl)buta-1,3-dienyl]-4-hydroxyoxan-2-one
3-Hydroxy-2-(1-hydroxy-3-oxopropan-2-yl)oxy-2-[1-[1-[1-(1-hydroxy-3-oxopropan-2-yl)oxy-2-oxoethoxy]-3-oxopropan-2-yl]oxy-2-oxoethoxy]propanal
6-[4-methoxy-3-(3-oxolanyloxy)phenyl]-3-(2-methoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
3-[4-[(4,6-Dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene)methyl]-3-(2-oxo-1-benzopyran-3-yl)-1-pyrazolyl]propanoic acid
5-[2-[[2-[[2-furanyl(oxo)methyl]amino]phenyl]-oxomethoxy]-1-oxoethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid ethyl ester
2-[[4-amino-5-[4-(difluoromethoxy)phenyl]-1,2,4-triazol-3-yl]thio]-N-[(2-furanylmethylamino)-oxomethyl]acetamide
3-chloranyl-N-[3-[[[(E)-(3-nitro-6-oxidanylidene-cyclohexa-2,4-dien-1-ylidene)methyl]amino]carbamoyl]phenyl]benzamide
1-[[1-[(3-Chlorophenyl)methyl]-2-oxo-3-indolylidene]amino]-3-(2-fluorophenyl)thiourea
2-(3-oxo-4H-1,4-benzothiazin-2-yl)acetic acid (7-acetamido-2-oxo-1-benzopyran-4-yl)methyl ester
N-[(6-chloro-2-oxo-4-phenyl-1H-quinolin-3-yl)methyl]-4-methylbenzenesulfonamide
1-(4-Bromophenyl)sulfonyl-4-[(3-methoxyphenyl)methyl]-1,4-diazepane
ethyl 4-[6-(4-oxo-2-sulfanylidene-1H-thieno[3,2-d]pyrimidin-3-yl)hexanoyl]piperazine-1-carboxylate
N-(4-acetylphenyl)-4-[[(E)-3-(4-fluorophenyl)-3-oxoprop-1-enyl]amino]benzenesulfonamide
N-(3-acetylphenyl)-4-[[(E)-3-(4-fluorophenyl)-3-oxoprop-1-enyl]amino]benzenesulfonamide
(3aR,4S,9aR,9bS)-N-(4-chlorophenyl)-2-(4-fluorophenyl)-1,3-dioxo-3a,4,9a,9b-tetrahydropyrrolo[1,2]pyrrolo[3,5-b]pyridazine-4-carboxamide
N-(4-chlorophenethyl)-2-(5-oxo-2,3-dihydrothiazolo[3,2:1,2]pyrimido[5,4-b]indol-6(5H)-yl)acetamide
(1S,5R)-7-[4-(2-fluorophenyl)phenyl]-3-(3-methoxyphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptane
(1S,5R)-3-(2-fluorophenyl)sulfonyl-7-[4-(3-methoxyphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane
(1R,5S)-6-(4-fluorophenyl)sulfonyl-7-[4-(2-methoxyphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane
(2R,3R)-cis-delta-viniferin
A stilbenoid that is the (2R,3R)-cis-stereoisomer of delta-viniferin, obtained by cyclodimerisation of cis-resveratrol.
(2S,3S)-cis-delta-viniferin
A stilbenoid that is the (2S,3S)-cis-stereoisomer of delta-viniferin, obtained by cyclodimerisation of cis-resveratrol.
(4,8-Dihydroxy-17-methoxy-10-oxo-2-oxatricyclo[13.2.2.13,7]icosa-1(17),3,5,7(20),15,18-hexaen-14-yl) hydrogen sulate
7-Chloro-2-(1-hydroxy-3-methoxy-4-oxocyclohexa-2,5-dien-1-yl)-3,5,6,8-tetramethoxychromen-4-one
3-[4-[(E)-3-(4-Bromophenyl)-3-oxoprop-1-enyl]-3-(4-methylphenyl)pyrazol-1-yl]propanoic acid
[(1S,2S,4R,8R)-8,10-diacetyloxy-4,8-dimethyl-7,13-dioxo-3,14-dioxatricyclo[9.3.0.02,4]tetradec-11-en-12-yl]methyl acetate
(4S,5R,6R)-6-[(1S)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;hydrate
8-Azaspiro[4.5]decane-7,9-dione, 8-[2-[[(2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amino]ethyl]-, monomethanesulfonate [CAS]
Hamaudol 3-glucoside
Sec-o-Glucosylhamaudol is a member of chromenes. sec-o-Glucosylhamaudol is a natural product found in Ostericum grosseserratum, Saposhnikovia divaricata, and other organisms with data available. Sec-O-Glucosylhamaudol is a natural compound extracted from Peucedanum japonicum Thunb, decreases levels of μ-opioid receptor, with analgesic effect[1]. Sec-O-Glucosylhamaudol is a natural compound extracted from Peucedanum japonicum Thunb, decreases levels of μ-opioid receptor, with analgesic effect[1]. Sec-O-Glucosylhamaudol is a natural compound extracted from Peucedanum japonicum Thunb, decreases levels of μ-opioid receptor, with analgesic effect[1].
1-(4-Methoxy-phenyl)-2-[6-methyl-2-(2-oxo-2-p-tolyl-ethylsulfanyl)-pyrimidin-4-ylsulfanyl]-ethanone
(+)-kotanin
A member of the class of 8,8-bicoumarins resulting from the formal oxidative dimerisation of 4,7-dimethoxy-5-methyl-2H-chromen-2-one (the S-(+) enantiomer). A fungal metabolite, its isolation from Aspergillus clavatus was first reported in 1971.
riboflavin cyclic 4,5-phosphate
A flavin mononucleotide that is riboflavin (vitamin B2) in which the 4 and 5 hydroxy groups have been converted into a cyclic hydrogen phosphate ester.
BMT-145027
BMT-145027 is an mGluR5 positive allosteric modulator without inherent agonist activity, exhibits an EC50 of 47 nM.
SIRT2-IN-9
SIRT2-IN-9 (compound 12) is a selective inhibitor of SRIT2 with an IC50 value of 1.3 μM. SIRT2-IN-9 inhibits proliferative activity of MCF-7 breast cancer cells. SIRT2-IN-9 can be used for the research of cancer[1].
VU 6008667
VU 6008667 is a selective negative allosteric modulator of M5 NAM with IC50s of 1.2 μM and 1.6 μM for human M5 and rat M5, respectively. High CNS penetration[1].
(8z)-2,16-dioxapentacyclo[22.2.2.1³,⁷.1¹⁷,²¹.0¹⁰,¹⁵]triaconta-1(26),3(30),4,6,8,10,12,14,17(29),18,20,24,27-tridecaene-4,12,22-triol
{4-[(1s,3ar,4s,6ar)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenyl}oxidanesulfonic acid
3,10-dihydroxy-9-{[6-hydroxy-2-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-3-yl]oxy}benzo[c]chromen-6-one
20,28-dihydroxy-4,11,18,25-tetraazaheptacyclo[14.11.1.0²,¹⁵.0³,¹².0⁵,¹⁰.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-2(15),3,5,7,9,11,13,17(26),20,22,24-undecaene-9-carboxylic acid
[(9r)-3,15-dihydroxy-16,17-dimethoxytricyclo[12.3.1.1²,⁶]nonadeca-1(17),2(19),3,5,14(18),15-hexaen-9-yl]oxidanesulfonic acid
1-{2,4-dihydroxy-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]phenyl}-3-(3,4-dihydroxyphenyl)-2-hydroxypropan-1-one
[4-(acetyloxy)-3,5-dihydroxy-6-[(6-methoxy-2-oxochromen-7-yl)oxy]oxan-2-yl]methyl acetate
methyl 3-(3,4-dihydroxyphenyl)-2-{6-[2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}prop-2-enoate
(1s,2r,6r,7z,11e)-3-methylidene-8-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-5,14-dioxatricyclo[10.2.1.0²,⁶]pentadeca-7,11-diene-4,13-dione
4,4',7,7'-tetramethoxy-5,5'-dimethyl-[6,8'-bichromene]-2,2'-dione
(3-hydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl 3,4-dihydroxybenzoate
13,14-dihydroxy-3-(4-hydroxyphenyl)-7-phenyl-5,10-dioxatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁶]hexadeca-1(9),2,6,11,13,15-hexaene-4,8-dione
[(1s,2e,8r,10s,11r)-8,10-bis(acetyloxy)-11-hydroxy-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-6-yl]methyl acetate
2-{2-[2-(2-isopropyl-4-methyl-5h-1,3-thiazol-4-yl)-4-methyl-5h-1,3-thiazol-4-yl]-4-methyl-5h-1,3-thiazol-4-yl}-4-methyl-1,3-thiazole
(2e)-1-(3,4-dihydroxyphenyl)-3-{3-[(3,4-dihydroxyphenyl)methyl]-6-hydroxy-2,4-dimethoxyphenyl}prop-2-en-1-one
4-hydroxy-6-[(1e)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pyran-2-one
2,6-dihydroxy-3-[(5-hydroxy-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl]benzoic acid
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[(1r,3r,4s)-4,8,10-trihydroxy-1,3-dimethyl-1h,3h,4h-naphtho[2,3-c]pyran-7-yl]oxy}oxane-3,4,5-triol
methyl 4a,5,6,7-tetrahydroxy-7-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylate
methyl (2e,4r,5r,6e)-7-{2-[2-(2-hydroxypropan-2-yl)-1,3-thiazol-4-yl]-1,3-thiazol-4-yl}-3,5-dimethoxy-4-methylhepta-2,6-dienoate
4-hydroxy-2,15-dioxapentacyclo[22.2.2.1³,⁷.1¹⁰,¹⁴.0¹⁶,²¹]triaconta-1(26),3(30),4,6,10,12,14(29),16(21),18,24,27-undecaene-17,20-dione
(1r,2r,4r,7s,9s,12s,13r,16r)-4-(furan-3-yl)-12-hydroxy-2,16-dimethyl-13-(methyldisulfanyl)-5,10-dioxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadecane-6,11-dione
2-(hydroxymethyl)-6-({4,8,10-trihydroxy-1,3-dimethyl-1h,3h,4h-naphtho[2,3-c]pyran-7-yl}oxy)oxane-3,4,5-triol
methyl 2',6-dihydroxy-5'-(3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl)-[1,1'-biphenyl]-3-carboxylate
2-(3,5-dichloro-2-hydroxy-6-methoxy-4-methylbenzoyl)-4,6-dihydroxy-3-(3-methylbut-2-en-1-yl)benzaldehyde
3-hydroxy-5-methylphenol1-o-β-d-(6'-galloyl)glucopyranoside
{"Ingredient_id": "HBIN008681","Ingredient_name": "3-hydroxy-5-methylphenol1-o-\u03b2-d-(6'-galloyl)glucopyranoside","Alias": "NA","Ingredient_formula": "C20H22O11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10512","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-O-galloylhomoarbutin
{"Ingredient_id": "HBIN012687","Ingredient_name": "6-O-galloylhomoarbutin","Alias": "NA","Ingredient_formula": "C20H22O11","Ingredient_Smile": "NA","Ingredient_weight": "438.38","OB_score": "1.668272535","CAS_id": "121748-24-1","SymMap_id": "SMIT03132","TCMID_id": "NA","TCMSP_id": "MOL000567","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}